Investigation of UGT1A1 Polymorphism and Pharmacokinetic Analysis on Irinotecan (CPT-11) and Its Metabolites for a Patient Who Developed Severe Neutropenia During Treatment With IFL Regimen

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
doi 10.5649/jjphcs.34.73
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Pharmaceutical Health Care and Sciences

Related search

Comprehensive Pharmacogenetic Analysis of Irinotecan Neutropenia and Pharmacokinetics

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Association Between UGT1A1 Gene Polymorphism and Safety and Efficacy of Irinotecan Monotherapy as the Third-Line Treatment for Advanced Gastric Cancer

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2019English

A Patient Who Developed a Brain Abscess During Treatment for Rectal Cancer Complicated by Liver Abscess

Nippon Daicho Komonbyo Gakkai Zasshi
2017English

Successful Treatment With Radiotherapy in a Patient Who Developed Severe Graves'-Like Ophthalmopathy After Treatment With Pegylated Interferon Alpha-2a for Hepatitis C

Endocrine Abstracts
2015English

A Patient With Diabetic Nephropathy Who Developed Bilateral Emphysematous Pyelonephritis During Peritoneal Dialysis

Nihon Toseki Igakkai Zasshi
2017English

A Population Pharmacokinetic Model for Simvastatin and Its Metabolites in Children and Adolescents

European Journal of Clinical Pharmacology
MedicinePharmacology
2019English

A Diabetic Patient on Hemodialysis Who Developed Penile Necrosis

Nihon Toseki Igakkai Zasshi
2009English

Imatinib Induced Severe Skin Reactions and Neutropenia in a Patient With Gastrointestinal Stromal Tumor

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

Phase II Trial of Temozolomide (TMZ) Plus Irinotecan (CPT-11) in Adults With Newly Diagnosed Glioblastoma Multiforme Before Radiotherapy

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy